The founder of Biontech expressed its trust that his vaccine was developing with Pfizer to combat the NCOV variant in India.

"We are still experimenting with Indian variants, but Indian variants have mutations that we have experimented and our vaccines are effective against them, so I'm confident about this issue"

A patient Covid-19 breathing oxygen in Ghaziabad, India on April 28.

"Vaccine is smartly produced and I believe 'walls' will hold. If we have to reinforce 'walls', we will do it, I don't worry about

India is facing a situation of new cases and deaths soaring, causing many people to concerns the variation from India as a factor contributing to disaster.

However, they have not yet declare it as "worrying variations", ie it is more dangerous than the original NCOV version, as capable of infection, lethal lethal or can dodge vaccines.

Pfizer-Biontech Vaccine is the first licensed vaccine in the West and it has been deployed in dozens of countries worldwide.